Sector consensus Cytosorbents Corporation
Stocks
CTSO
US23283X3052
Advanced Medical Equipment & Technology
|
Market Closed -
Nasdaq
16:00:00 2026-09-10 EDT
|
5-day change | 1st Jan Change | ||
| 6.370 USD | +0.63% |
|
-17.01% | -50.17% |
| 08-06 | Cytosorbents Corporation, Q2 2026 Earnings Call, Aug 06, 2026 | |
| 08-06 | Cytosorbents Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | - | - | 47.5 | +650.39% | 2 | ||||
| 645.15 | +6.51% | 27 | ||||||
| 229.09 | +11.83% | 23 | ||||||
| 478.01 | +35.32% | 30 | ||||||
| 62.41 | +38.82% | 29 | ||||||
| 45.52 | +17.66% | 19 | ||||||
| 100.96 | +17.15% | 26 | ||||||
| 174.95 | +20.87% | 21 | ||||||
| 442.71 | +9.36% | 24 | ||||||
| 202.65 | -1.15% | 20 | ||||||
| 246.44 | +12.04% | 16 | ||||||
| 229.51 | +38.93% | 17 | ||||||
| 82.5 | +26.59% | 18 | ||||||
| 27 | +24.63% | 20 | ||||||
| 126.12 | +1.83% | 17 | ||||||
| 2,161.54 | +12.08% | 13 | ||||||
| 59.23 | +8.82% | 13 | ||||||
| 121.8 | -3.23% | 5 | ||||||
| 9.983 | +37.42% | 6 | ||||||
| Average | 289.11 | +50.84% | 18 | ||||||
| Weighted average by Cap. | 354.27 | +17.62% | 24 |
- Stock Market
- Stocks
- CTSO Stock
- Sector Cytosorbents Corporation
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
